Evidence Hub

Actinomyces neuii in chronic hidradenitis suppurativa: a case series highlighting the value of extended culture

Balji B, Lönndahl L, Emtestam L, Sandberg C, Killasli H

Skin health and disease, 2026

Abstract

Hidradenitis suppurativa (HS) is a chronic, relapsing inflammatory skin disease characterized by painful nodules, sinus tract formation and scarring. Lesional skin is frequently colonized by diverse aerobic and anaerobic bacteria, with anaerobes such as Prevotella spp., Campylobacter ureolyticus, Staphylococcus epidermidis and Actinomyces spp. commonly isolated. Actinomyces neuii, a Gram-positive, slow-growing anaerobe, has been previously described only occasionally in deep HS abscesses. We present three cases of treatment-resistant HS in which extended incubation of cultures yielded A. neuii. All patients were subsequently treated with long-term amoxicillin (3-6 months), resulting in marked clinical improvement. These findings suggest a potential pathogenic role for A. neuii in severe HS. Further research is required to establish its clinical relevance, evaluate optimal antibiotic regimens and monitor for resistance development.

How strong is the evidence?

Evidence Hub reads this as a case series, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free